Back to 
Candriam S.C.A.
Candriam S.C.A.
MNPR1 quarters
Position history for Candriam S.C.A.'s holdings in MONOPAR THERAPEUTICS INC
Candriam S.C.A. holds 143,339 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $13.3M as of 2026-Q2. This is a new position. MNPR represents 0.1% of Candriam S.C.A.'s portfolio.
Current Value
$13.3M
Current Shares
143,339
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.